$41B
$878 Million
0.02% of portfolio
2,106
Q1 2024
Reduced 89.79%
$48.4B
$1 Billion
0.02% of portfolio
1,958
Q1 2024
Reduced 48.2%
$36.1B
$1.14 Billion
0.02% of portfolio
5,489
Q1 2024
Reduced 71.84%
$43.6B
$969 Million
0.02% of portfolio
3,934
Q1 2024
Reduced 77.5%
$37.7B
$1.17 Billion
0.02% of portfolio
10,033
Q1 2024
Reduced 55.17%
$13.7B
$1.31 Billion
0.02% of portfolio
8,151
Q1 2024
Reduced 65.32%
$6.49B
$933 Million
0.02% of portfolio
7,702
Q1 2024
Reduced 88.43%
$34.4B
$849 Million
0.02% of portfolio
6,727
Q1 2024
Reduced 93.84%
$8.72B
$1.26 Billion
0.02% of portfolio
3,177
Q1 2024
Reduced 78.16%
$19.5B
$1.06 Billion
0.02% of portfolio
16,375
Q1 2024
Reduced 63.65%
$36B
$1.32 Billion
0.02% of portfolio
23,257
Q1 2024
Reduced 75.85%
$11.9B
$1.05 Billion
0.02% of portfolio
9,884
Q1 2024
Reduced 3.76%
Halozyme Therapeutics Inc
-
$1.08 Billion
0.02% of portfolio
-
Q1 2024
Added 100.0%
$43.1B
$1.3 Billion
0.02% of portfolio
3,829
Q1 2024
Reduced 77.56%
$55.3B
$1.04 Billion
0.02% of portfolio
84,300
Q1 2024
New
$12.6B
$1.04 Billion
0.02% of portfolio
33,225
Q1 2024
Reduced 73.61%
$58.7B
$1.26 Billion
0.02% of portfolio
8,139
Q1 2024
Reduced 76.12%
$27B
$1.37 Billion
0.02% of portfolio
4,835
Q1 2024
Reduced 35.11%
$17.5B
$1.3 Billion
0.02% of portfolio
16,881
Q1 2024
Reduced 51.88%
$34.5B
$914 Million
0.02% of portfolio
9,790
Q1 2024
Reduced 64.83%
-
$1.26 Billion
0.02% of portfolio
-
Q1 2024
Reduced 31.03%
$20B
$917 Million
0.02% of portfolio
3,599
Q1 2024
Reduced 54.19%
$14.3B
$1.21 Billion
0.02% of portfolio
7,711
Q1 2024
Added 4.44%
Ironwood Pharmaceuticals Inc
-
$920 Million
0.02% of portfolio
-
Q1 2024
New
$7.69B
$1.2 Billion
0.02% of portfolio
21,422
Q1 2024
New
-
$1.01 Billion
0.02% of portfolio
-
Q4 2023
New
$51.6B
$1.08 Billion
0.02% of portfolio
10,622
Q1 2024
Reduced 57.34%
$56.3B
$1.12 Billion
0.02% of portfolio
6,358
Q1 2024
Reduced 57.33%
$23.9B
$1.11 Billion
0.02% of portfolio
8,566
Q4 2023
New
$26.8B
$1.35 Billion
0.02% of portfolio
3,790
Q1 2024
Added 210.91%
$15.5B
$1.01 Billion
0.02% of portfolio
12,454
Q1 2024
Reduced 57.34%
$10.2B
$396 Million
0.01% of portfolio
760
Q1 2024
Reduced 60.46%
-
$388 Million
0.01% of portfolio
-
Q4 2023
New
$42.9B
$596 Million
0.01% of portfolio
2,527
Q1 2024
Reduced 65.6%
-
$499 Million
0.01% of portfolio
-
Q4 2023
New
$6.7B
$598 Million
0.01% of portfolio
3,252
Q1 2024
Added 30.39%
$17.6B
$588 Million
0.01% of portfolio
36,020
Q1 2024
Reduced 50.94%
$28.4B
$343 Million
0.01% of portfolio
1,781
Q1 2024
Reduced 3.47%
$68.7B
$619 Million
0.01% of portfolio
3,346
Q1 2024
New
$6.98B
$805 Million
0.01% of portfolio
6,346
Q1 2024
Reduced 57.33%
$37.2B
$397 Million
0.01% of portfolio
19,929
Q1 2024
New
$6.59B
$705 Million
0.01% of portfolio
6,139
Q1 2024
Reduced 78.88%
$30.6B
$288 Million
0.01% of portfolio
17,283
Q1 2024
New
$200B
$622 Million
0.01% of portfolio
8,591
Q1 2024
New
-
$613 Million
0.01% of portfolio
-
Q4 2023
New
Alnylam Pharmaceuticals Inc
-
$524 Million
0.01% of portfolio
-
Q4 2023
New
$71.9B
$308 Million
0.01% of portfolio
2,742
Q1 2024
Reduced 18.03%
-
$499 Million
0.01% of portfolio
-
Q1 2024
Reduced 16.67%
$17.8B
$655 Million
0.01% of portfolio
18,457
Q1 2024
Added 104.65%
-
$676 Million
0.01% of portfolio
-
Q4 2023
New